Premature infants born at 34 and 35 weeks differ in respiratory issues and length of stay due to feeding difficulties

Hiroki Sugiyama1, Yuji Hirai1, Saori Deki1

  • 1Pediatrics, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan.

Insights

A one-week difference in gestational age significantly impacts late preterm infant outcomes. Thirty-four-week infants experienced longer hospital stays due to feeding issues, not respiratory problems.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Pediatric Outcomes Research

Background:

  • Late preterm infants (34-36 weeks gestation) generally have better prognoses than earlier preterm infants.
  • Subtle differences within the late preterm group remain underexplored.
  • Gestational age is a critical factor in neonatal development and outcomes.

Purpose of the Study:

  • To compare clinical outcomes between infants born at 34 weeks and 35 weeks of gestation.
  • To identify specific differences in morbidity and hospital course between these two subgroups.
  • To inform management strategies for late preterm infants.

Main Methods:

  • Retrospective analysis of hospital records from April 2020 to March 2024.
  • Exclusion of cases with complications.
  • Statistical analysis using Fisher's χ2 test, Mann-Whitney U test, and simple linear regression.

Main Results:

  • Infants born at 34 weeks had lower Apgar scores and higher rates of requiring respiratory assistance at birth.
  • Thirty-four-week infants experienced longer durations of intravenous therapy and delayed autonomous feeding.
  • Prolonged hospital stays in 34-week infants were primarily associated with feeding difficulties, not respiratory morbidity (median stay: 17 days vs. 10 days).

Conclusions:

  • A one-week difference in gestational age significantly impacts clinical outcomes in late preterm infants.
  • Feeding difficulties, rather than respiratory issues, are a key driver of prolonged hospital stays for 34-week infants.
  • Current uniform management approaches for late preterm infants may need re-evaluation based on gestational age subgroups.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.8K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
532
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289